Back
Seres Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
MCRB
Seres Therapeutics, Inc.
Last Price:
$14.56
Seasonality Move:
-11.78%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Seres Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.03 | Sell |
| 20-day SMA: | 16.17 | Sell |
| 50-day SMA: | 16.95 | Sell |
| 200-day SMA: | 14.14 | Buy |
| 8-day EMA: | 15.19 | Sell |
| 20-day EMA: | 16 | Sell |
| 50-day EMA: | 16.78 | Sell |
| 200-day EMA: | 16.16 | Sell |
Seres Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 42.24 | Sell |
| Chaikin Money Flow: | 62349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.34 - 17.44) | Sell |
| Bollinger Bands (100): | (15.3 - 20) | Sell |
Seres Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics, Inc. Stock
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 14.92 while MCRB 8-day simple moving average is 15.03, which is a Sell signal.
-
The stock price of MCRB is 14.92 while Seres Therapeutics, Inc. 20-day SMA is 16.17, which makes it a Sell.
-
Seres Therapeutics, Inc. 50-day simple moving average is 16.95 while MCRB share price is 14.92, making it a Sell technically.
-
MCRB stock price is 14.92 and Seres Therapeutics, Inc. 200-day simple moving average is 14.14, creating a Buy signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
18
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. a Buy or a Sell?
-
Seres Therapeutics, Inc. stock is rated a SellThe current Seres Therapeutics, Inc. [MCRB] share price is $14.92. The Score for MCRB is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics, Inc. Stock Info
Market Cap:
130.6M
Price in USD:
14.92
Share Volume:
104.5K
Seres Therapeutics, Inc. 52-Week Range
52-Week High:
29.98
52-Week Low:
6.53
Sell
18
Seres Therapeutics, Inc. (MCRB)
is a Sell
Seres Therapeutics, Inc. Share Price Forecast
-
What is the Seres Therapeutics, Inc. stock price today?The Seres Therapeutics, Inc. stock price is 14.92 USD today.
-
Will MCRB stock go up or go down?Seres Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Seres Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics, Inc. is overvalued.
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 14.92 while MCRB 8-day exponential moving average is 15.19, which is a Sell signal.
-
The stock price of MCRB is 14.92 while Seres Therapeutics, Inc. 20-day EMA is 16.00, which makes it a Sell.
-
Seres Therapeutics, Inc. 50-day exponential moving average is 16.78 while MCRB share price is 14.92, making it a Sell technically.
-
MCRB stock price is 14.92 and Seres Therapeutics, Inc. 200-day simple moving average is 16.16, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics, Inc.
Is Seres Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Seres Therapeutics, Inc.
Should I short Seres Therapeutics, Inc. stock?
-
MCRB Moving Average Covergence Divergence (MACD) indicator is -0.77, suggesting Seres Therapeutics, Inc. is a Sell
-
Seres Therapeutics, Inc. Relative Strength Index (RSI) is 42.24, which suggest Seres Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Seres Therapeutics, Inc. is (15.34 - 17.44), which suggest Seres Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Seres Therapeutics, Inc. is (15.3 - 20), which suggest Seres Therapeutics, Inc. is a Sell
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.